Equity High Tech Patents 
InfoChachkie
JANUARY 6, 2014
An invalidated patent or one deemed to infringe the rights of another party can devastate a startup. Defensible Claims - Some companies take pride in the number of patents they own. However, there is not a direct correlation between a patent portfolio’s value and the number of patents which comprise the portfolio.
Startup Professionals Musings
SEPTEMBER 22, 2011
Yet, according to many sources , over 90 percent of all businesses are started and grown with no equity financing, and many others would have been better off without it. In fact, most of the rich entrepreneurs you know actively turned away early equity proposals. Of course, every company needs these, in due time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Startup Professionals Musings
DECEMBER 23, 2013
Yet, according to many sources , over 90 percent of all businesses are started and grown with no equity financing, and many others would have been better off without it. In fact, most of the rich entrepreneurs you know actively turned away early equity proposals. Of course, every company needs these, in due time.
Startup Professionals Musings
NOVEMBER 13, 2012
Yet, according to many sources , over 90 percent of all businesses are started and grown with no equity financing, and many others would have been better off without it. In fact, most of the rich entrepreneurs you know actively turned away early equity proposals. Of course, every company needs these, in due time.
Xconomy
MAY 30, 2016
Our wide-ranging conversation covered the progression of MIT’s entrepreneurship curriculum and campus resources , the rise of the Boston-Cambridge area as a high-tech industry powerhouse, the prospects for an MIT venture fund , the challenges for university tech transfer offices, the roots of today’s startup culture, and more.
Xconomy
JUNE 3, 2016
Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). —When Merck (NYSE: MRK ) bought Cubist Pharmaceuticals for $9.5
InfoChachkie
OCTOBER 24, 2011
There has recently been a common theme among the entrepreneurs I have interviewed and the conferences I have attended: despite the relatively weak state of the world economy, now is a great time to create a high-tech startup. As Guy Kawasaki pointed out in our recent conversation , “…it is cheaper than ever to start a company.
Expert insights. Personalized for you.
210 
Let's personalize your content